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Abstract: Glutathione peroxidase 3 (GPx3) belongs to the glutathione peroxidase family of selenoproteins
and is a key antioxidant enzyme in multicellular organisms against oxidative damage. Downregulation
of GPx3 affects tumor progression and metastasis and is associated with liver and heart disease.
However, the physiological significance of GPx3 in vertebrate embryonic development remains poorly
understood. The current study aimed to investigate the functional roles of gpx3 during embryogenesis.
To this end, we determined gpx3’s spatiotemporal expression using Xenopus laevis as a model organism.
Using reverse transcription polymerase chain reaction (RT-PCR), we demonstrated the zygotic nature
of this gene. Interestingly, the expression of gpx3 enhanced during the tailbud stage of development,
and whole mount in situ hybridization (WISH) analysis revealed gpx3 localization in prospective tail
region of developing embryo. gpx3 knockdown using antisense morpholino oligonucleotides (MOs)
resulted in short post-anal tails, and these malformed tails were significantly rescued by glutathione
peroxidase mimic ebselen. The gene expression analysis indicated that gpx3 knockdown significantly
altered the expression of genes associated with Wnt, Notch, and bone morphogenetic protein (BMP)
signaling pathways involved in tailbud development. Moreover, RNA sequencing identified that
gpx3 plays a role in regulation of cell death in the developing embryo. Terminal deoxynucleotidyl
transferase dUTP nick end labeling (TUNEL) and phospho-histone 3 (PH3) staining confirmed the
association of gpx3 knockdown with increased cell death and decreased cell proliferation in tail region
of developing embryos, establishing the involvement of gpx3 in tailbud development by regulating
the cell death. Furthermore, these findings are inter-related with increased reactive oxygen species
(ROS) levels in gpx3 knockdown embryos, as measured by using a redox-sensitive fluorescent probe
HyPer. Taken together, our results suggest that gpx3 plays a critical role in posterior embryonic
development by regulating cell death and proliferation during vertebrate embryogenesis.
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1. Introduction
Reactive oxygen species (ROS) are highly reactive chemical species that contain oxygen in the form
of reactive superoxide anions, hydrogen peroxides, or hydroxyl radicals [1]. In recent years, ROS have
been recognized as important signaling molecules that play a role in early embryonic development and
regeneration [2]. Maintaining high levels of hydrogen peroxide is required for Wnt/β-catenin signaling
and fibroblast growth factor (FGF) signaling activation during Xenopus tail regeneration [3]. An ROS
burst is observed after fertilization in sea-urchins and Xenopus [4]. ROS play essential roles during egg
cleavage and mesoderm formation during vertebrate embryogenesis [5]. However, excessive ROS
damage can affect various cells and biological processes [1,6]. Therefore, ROS homeostasis is required
for steady-state biological and cellular processing [1,6,7].
Cells use different enzymatic and non-enzymatic antioxidants to maintain ROS homeostasis [6,7].
Glutathione peroxidase (GPx) is a multiple isozyme group that is involved in converting hydrogen
peroxide (H2O2) or organic hydrogen peroxide to water using reduced glutathione as an electron
donor [8]. Some GPxs have selenium-dependent glutathione peroxidase activity [9]. In mammals,
four selenium dependent GPxs are broadly distributed in different mammalian tissues: GPx1, GPx2,
Gpx3, and GPx4, [10].
Glutathione peroxidase 3 (GPx3), also known as plasma GPx, is present in various organs,
including kidney, lung, heart, muscles, epididymis, vas deferens, placenta, and seminal vesicles [11–13].
GPx3 forms a homotetramer and is a secreted protein that is also present in the cytoplasm [14].
GPx3 plays a crucial role in ROS detoxification. Studies have shown that GPx3 silencing promotes
tumor metastasis in human gastric and thyroid cancer [15]. Recent reports suggest that GPx3 ablation
enhances tumor inflammation, injury, proliferation, and DNA damage in mice subjected to inflammatory
carcinogenesis and chronic colitis [16]. Hyper-methylation-mediated downregulation of GPx3 was also
observed in breast, ovarian, gastric, esophagus, and prostate cancer [17–21]. In addition to its anticancer
role, high GPx3 levels alleviate cardiovascular disease-associated mortality [22]. GPx3 downregulation
enhances liver aging, and an inadequate GPx3 level is a significant factor in human heart disease [23,24].
However, GPx3’s role during early embryonic development remains elusive.
In this study, we investigated gpx3 developmental functions during Xenopus embryogenesis.
Analyzing gpx3’s spatiotemporal expression pattern revealed that it is expressed in the tailbud region.
gpx3 knockdown resulted in a shortened post-anal tail and increased ROS levels. Whole mount
in situ hybridization (WISH) analysis indicated that gpx3 is not involved in the tailbud structure.
However, gpx3 depletion induced cell death and decreased cell proliferation in the tailbud region.
These findings suggest that gpx3 plays a significant role in the tailbud extension during Xenopus
embryonic development.
2. Materials and Methods
2.1. Xenopus Growth Conditions and In Vitro Fertilization
Adult X. laevis were obtained from the Korean Xenopus Resource Center for Research and were
housed at 18 ◦C with a 12 h photoperiod in containers recommended by the Ulsan National Institute
of Science and Technology Institutional Review Board. To induce ovulation, Xenopus females were
injected with 1000 IU of human chorionic gonadotropins into the dorsal lymph sac the evening before
the experiment. The next morning, females were transferred to a 1x high salt solution for egg harvesting.
For fertilization, male Xenopus were kept in a 1x benzocaine solution for 5–15 min and were then
sacrificed to isolate the testes. The isolated testes were kept in 1x modified Barth’s saline (MBS) at 4 ◦C.
The eggs were washed with 0.1x MBS three times and were then fertilized with a sperm suspension
solution derived from the isolated testes. After fertilization, the eggs were de-jellied by swirling
them in 2% L-cysteine and were then washed five times with 0.5x MBS. The unfertilized and dead
eggs were removed. The fertilized eggs were cultured at 15–18 ◦C in 0.5x MBS containing 2% Ficoll
400 (GE Healthcare, Little Chalfont, UK) after injections.
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2.2. Plasmids and mRNA Synthesis
As gpx3 has a UGA opal codon within the coding sequence, to avoid translation termination
and confirm morpholino oligonucleotides (MO) specificity, we cloned a mutant construct that has the
selenocysteine changed to cysteine. DNA was isolated from tailbud stage Xenopus. gpx3 primers were
designed based on the gpx3 sequences listed in Xenbase and NCBI. Flag-tagged U73C gpx3 mRNA was
synthesized using PCR, and the plasmid was constructed using the pCS107 vector with ClaI and XhoI
restriction sites.
The HyPer-cyto gene was obtained from pHyPer-cyto (Evrogen, Moscow, Russia) and subcloned
into the pCS2+ vector. HyPer-pCS2+ was linearized using the NotI restriction enzyme. SP6 mMessage
mMachine kit was used to synthesize mRNA (Ambion, Woodward Street, Austin, TX, USA).
2.3. MO Design and Xenopus Embryo Microinjection
A 25-nucleotide gpx3 MO (Gene Tools) was designed to bind the gpx3 mRNA translation initiation
region. The Xenopus gpx3 translation-blocking MO sequence was 5′-atgggggtcaaatttagggggctct-3′,
and the splicing-blocking MO sequence was 5′-acgcacatacctggcagtcaaaaac-3′. MOs were injected into
the embryo’s ventral blastomere at the 4-cell stage, and green fluorescent protein mRNA was co-injected
as a lineage tracer. Ebselen, a GPx chemical mimic, was used to perform the rescue experiments.
2.4. Whole-Mount In Situ Hybridization
The gpx3 MO was injected into the Xenopus embryos ventral region at the 4-cell stage.
The MO-injected embryos were collected at the desired stage and were fixed in fixative
MEMFA (4% paraformaldehyde, 0.1 M MOPS buffer (pH 7.4), 1 mM MgSO4, 2 Mm ethylene
glycol-bis(β-amino ethyl ether)-N,N,N′,N′-tetraacetic acid (EGTA) overnight at 4 ◦C. The embryos
were dehydrated before storage in 100% methanol at −20 ◦C. To prepare the antisense digoxigenin
(DIG)-labeling probes, DNA templates were linearized using appropriate restriction enzymes.
Probes were synthesized using SP6 or T7 RNA polymerase (Ambion) and were detected using
an alkaline phosphatase-labeled antidigoxigenin antibody (1:1000, Roche, Basel, Switzerland) or nitro
blue tetrazolium/5-bromo-4-chloro-3indolyl phosphate (NBT/BCIP) [25].
2.5. Reverse Transcription Polymerase Chain Reaction
Total RNA was extracted from Xenopus embryos using Isol-RNA lysis reagent (5 Prime GmbH,
Hilden, Germany). cDNA was synthesized from total RNA of Xenopus embryos using the PrimeScript
first-strand cDNA synthesis kit (Takara, Kusatsu, Japan). PCR was performed using customized
primers, (Table 1) and the products were loaded on 1% agarose gels. Images were captured using
WiseCapture I-1000 (Daihan Scientific, Wonju, South Korea).
Table 1. List of Primers for RT-PCR
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2.6. Transcriptomic Analysis
An RNA sequencing (RNA-seq) library was constructed from total RNA extracted from each
sample with polyA enrichment, according to the manufacturer’s instructions (Illumina). To estimate
the mRNA abundance, X. laevis cDNA sequence reads were mapped from the genome project
consortium [26] using bwa (version 0.7.15). EdgeR (version 3.20.7) was used to analyze differentially
expressed genes (DEGs). Significantly differentially expressed genes had a >2-fold change with a false
discovery rate (FDR) <0.01 in an exact test. Over-represented biological processes in the DEGs were
tested using Fisher’s test and PANTHER database (released 20171205). Human orthologous genes
were determined based on best hits using the BLASTP search. Raw data for the RNA-seq is available
at the NCBI GEO database (PRJEB39362) [27].
2.7. Terminal Deoxynucleotidyl Transferase dUTP Nick End Labeling (TUNEL) and Phospho-Histone 3
(PH3) Staining
Xenopus embryos were fixed for 24 h in MEMFA at 4 ◦C and bleached (3% H2O2, 5% formamide,
and 5xsaline sodium citrate (SSC)) after washing with phosphate buffer saline (PBS). The embryos
were processed for TUNEL and PH3 staining, as described previously [28].
2.8. In Vivo Imaging of ROS
HyPer cyto (HyPer) was used to detect H2O2 related ROS. HyPer mRNAs (10 ng) were injected
into the 1-cell staged embryos. Images were taken using live anesthetized embryos using 1:1000
diluted benzocaine and an Olympus FV1200 confocal microscope. Images were analyzed by ImageJ
[Cite Schneider, C. A.; Rasband, W. S. & Eliceiri, K. W. (2012), “NIH Image to ImageJ: 25 years of image
analysis”, Nature methods 9(7): 671-675, PMID 22930834 ].
2.9. Statistical Analysis
WISH and RT-PCR data were analyzed using ImageJ. Results are presented as the mean± standard
error from three independent experiments. Results were interpreted by unpaired t-test (two-tailed)
using GraphPad Prism 7 software (GraphPad Software Inc., La Jolla, CA, USA). P-values of less than
0.05 were considered statistically significant. P-values were represented by asterisk (*).
3. Results
3.1. Gpx3 Spatiotemporal Expression Pattern during Xenopus Embryogenesis
To determine the specific gpx3 roles during Xenopus embryonic development, we first analyzed
the gpx3 expression pattern in Xenopus. RT-PCR was conducted to assess the temporal gpx3 expression.
RT-PCR indicated that gpx3 is first expressed at the gastrula stage (Nieuwkoop and Faber; St.12)
of Xenopus embryos (Figure 1A). The highest expression levels were observed at the tailbud stage
(NF. St.20-25). Expression was observed until later development stages, such as the late tailbud stage
(St.40; Figure 1A). RT-PCR revealed the zygotic nature of gpx3, with the highest expression level at the
early tailbud stage in Xenopus embryos.
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catenin  signaling  is  required  for posterior development, and many Wnt  signaling genes,  such as 
Figure 1. gpx3 is req ire for tailbud development during Xenopus embryonic development. (A) RT-PCR
analysis indicated the zygotic gpx3 gene expression. gpx3 expression started at the gastrula stage
of develop ent (St.12) and continued until later stages (St.40). The highest expression levels ere
observed at the tailbud stage (St.20-25). Ornithine decarboxylase (odc) was used as an internal control.
(B) hole mount in situ hybridization (WISH) analysis demonstrated gpx3 expression at the prospective
tailbud region (St.23) and exhibited its localization in the developing embryo tail region (St.31). (C) gpx3
morpholino oligonucleotides (MO) microinjection into the 4-cell stage embryo ventral side resulted in
short post-anal tails in gpx3 morphant embryos compared to control MO-injected embryos. Malformed
phenotypes induced by gpx3 knockdown were effectively rescued by ebselen, a GPx mimic. (D) Embryo
phenotype quantification revealed that more than 90% of the injected embryos with gpx3 MO developed
short post-anal tails compared to control embryos. The short tail phenotypes were 50% recovered in
ebselen-treated embryos. * p < 0.05, **** p < 0.0001.
WISH analysis determined the gpx3 spatial expression during Xenopus embryonic development.
Our results showed the gpx3 expression in the developing embryo prospective tailbud region (NF. St.23)
and in the tail region of later stage embryos (NF. St. 31; Figure 1B). These results suggest that gpx3 may
be involved in tailbud developme t during Xenopus embryogenesis.
3.2. Gpx3 Knockdown Leads to a Reduced Post-Anal Tail during Embryonic Development
To evaluate our hypothesis that gpx3 is involved in tailbud development, loss of function
experiments were performed using antisense MO against gpx3. To check the specificity and the
efficiency of MO against gpx3, we used translational blocking MO and splicing blocking MO. These gpx3
MOs were microinjected into the ventral region of Xenopus embryos at the 4-cell stage to repress gpx3
expression. Microinjection of the gpx3 MOs resulted in a shortened post-anal tail in the morphant
embryos compared to control embryos (Figure 1C). It was revealed that more than 90% of the embryos
injected with the gpx3 MO exhibited reduced tail development (Figure 1D).
To further determine the gpx3 role in tailbud development and to confirm the gpx3 specificity,
we conducted rescue experiments using ebselen, which mimics glutathione peroxidase [29]. Ebselen
has free-radical and singlet oxygen quenching properties and catalyzes the hydrogen peroxide
reduction similar to glutathione peroxidase at the expense of thiol [29]. The reason for performing
rescue experiments using ebselen was the non-availability of gpx3 specific antibodies in Xenopus.
Thus, to rescue the gpx3 MO-induced malformations, we injected gpx3 MO into the Xenopus embryos
at the 4-cell stage and transferred them to a 1 µM ebselen solution. Approximately 50% of the
gpx3 MO-injected embryos grown in the ebselen media recovered from the malformations that were
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observed in gpx3 morphant embryos (Figure 1C,D). Taken together, these findings demonstrate the
gpx3 MO specificity, which is responsible for a shortened post-anal tail in gpx3 morphant embryos.
3.3. Gpx3 Mediates Tailbud Development through Wnt, Notch, and FGF Signaling Pathway Regulation
In Xenopus, tailbud development is regulated by different signaling pathways. Active Wnt/β-catenin
signaling is required for posterior development, and many Wnt signaling genes, such as wnt3a, wnt5,
and wnt8, are expressed in the posterior portion of the developing embryos [30,31]. In addition
to Wnt, Notch and bone morphogenetic protein (BMP) signaling also play critical roles in tailbud
outgrowth [32,33]. FGF proteins are also involved in posterior patterning, and Xtbx6 mediates posterior
development through Wnt and FGF signaling regulation [34]. To evaluate gpx3’s role in posterior
development signaling pathway regulation, we microinjected Xenopus embryos with gpx3 MO and
assessed Wnt gene expression via RT-PCR. We assessed wnt3a, wnt5a, wnt5b, notch1, fgf8, and Xtbx6
expression in the excised posterior part of morphant embryos. The expressions of wnt3a, wnt5b,
notch1, and fgf8 were significantly reduced in gpx3-depleted embryos compared to control embryos
(Figure 2A,B). Overall, gpx3 is involved in posterior development by influencing Wnt, Notch, and BMP
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Figure 2. gpx3 knockdown perturbed Wnt, Notch, and FGF signaling gene expression but did not
affect the early tailbud gene expression. (A,B) gpx3 MO was injected into the ventral regions of 4-cell
stage embryos, and RT-PCR was used to determine wnt3a, wnt5a, wnt5b, notch1, fgf8, and Xtbx6 gene
expression after removing the anterior part of embryos. wnt3a, wnt5b, notch1, and fgf8 expressions
were significantly reduced in gpx3 MO-injected embryos. * p < 0.05; ** p < 0.001; *** p < 0.0001;
ns, not significant. (C) WISH analysis of gpx3 morphant embryos using Xbra and Xnot2 (chordoneural
hinge and posterior wall markers). gpx3 knockdown did not affect the early tailbud gene expression.
(D) RT-PCR of Xbra and Xnot2 relative expression revealed no significant differences between the
control and gpx3 MO-injected embryos.
3.4. Gpx3 Knockdown Does Not Perturb Early Tailbud Gene Expression
Tailbud outgrowth is regulated by the expression of two gene sets, which are categorized as early
and late genes [35,36]. Early genes (X-delta-1, Xlim1, Xbra, Xnot2, and Xcad3) are expressed in the future
tailbud regions, while late genes (lunatic fringe, LFNG) are expressed at the time of tailbud extension,
forming the axial tail tissues [37].
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Because gpx3 knockdown disrupted normal tail development in Xenopus embryos, we speculated
that gpx3 may be involved in the early tailbud gene regulation. To investigate gpx3’s functional
role in tailbud development, we performed a loss of function experiment using the gpx3 MO and
analyzed its effect on the expression of two tailbud early genes, Xbra and Xnot2. The T-box factor,
Xbra, is expressed in the chordoneural hinge and the posterior wall, whereas the homeobox factor,
Xnot2, is expressed in the ventral neural tube and the chordoneural hinge. Embryos at the 4-cell stage
were ventrally injected with a gpx3 MO, and WISH was used to evaluate Xbra and Xnot2 tailbud
expression. Surprisingly, the WISH analysis showed that gpx3 knockdown did not affect Xbra and
Xnot2 tailbud expression. The expression of both tailbud markers was the same in control embryos and
gpx3 morphant embryos, and no significant physical alterations were observed (Figure 2C). To confirm
the WISH data, we performed RT-PCR using primers specific for Xbra and Xnot2. The RT-PCR
results demonstrated that there were no appreciable expression differences for Xbra and Xnot2 in gpx3
MO-injected embryos (Figure 2D), consistent with WISH data. Taken together, these findings suggest
that gpx3 depletion had no functional significance in regulating early tailbud gene expression.
3.5. Gpx3 Regulates ROS Level in the Tailbud Region
To assess gpx3’s antioxidant function, we microinjected HyPer mRNA into 1-cell staged embryos
and subsequently microinjected gpx3 MO into the embryos once at the 4-cell stage. Compared to control
embryos, gpx3 knockdown embryos showed increased HyPer fluorescent intensity, representing
increased H2O2 levels related to ROS (Figure 3A,B). These results demonstrate that gpx3 has an
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3.6. Gpx3 Is Required for Regulating Programmed Cell Death during Xenopus Embryogenesis
We performed transcriptome analysis of gpx3-depleted embryos to identify specific genes that
are regulated by gpx3 during Xenopus embryonic development. Total RNA from gpx3 morphants was
extracted and processed for transcriptome analysis. Our transcriptome analysis revealed that there were
significant differences in the overall transcript expression between the control and the gpx3 MO-injected
embryos (Figure 4A). gpx3 knockdown led to upregulation in genes related to apoptosis signaling,
toll receptor signaling, and Fas signaling pathways (Figure 4B,C). Thus, our transcriptome analysis
suggests that the shortened tail in gpx3 morphants is the result of cell death in the posterior regions.

















Figure 4. Effects of gpx3 knockdown on the Xenopus embryo transcriptome. (A) Heat map showing
significant differences between control and gpx3 MO-injected embryos. (B) Transcriptome enrichment
analysis using PANTHER indicated that cell death processes are significantly upregulated in
gpx3-depleted embryos. (C) Gene ontology (GO-terms) and genes also indicated that genes associated
with apoptosis and cell-death-related pathways were significantly affected by gpx3 depletion. (D) The
expression of Nrf2 and its putative targets were not affected by gpx3 knockdown.
Since the knockdown of gpx3 is associated with increased level of ROS in morphant embryos,
and enhanced ROS levels can lead to activation of Nrf2. Thus, we checked our RNA-seq data to
see whether Nrf2 (Nfe2l2) and their putative targets were induced by gpx3 knockdown. However,
expression levels of two duplicated genes (homologs) of nfe2l2 (nfe2l2.L and nfe2l2.S) were not changed
significantly (Figure 4D). Further, we also checked the target of Nrf2 related to ROS, and they also did not
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show any change by depleting gpx3 (Figure 4D). Although Nrf2 regulates many ROS detoxifying genes,
our transcriptomic data showed that the gpx3 knockdown might not activate Nrf2 regulatory network.
To verify gpx3’s role in cell death gene expression, a TUNEL assay and phospho-H3 staining were
performed. In the gpx3 knockdown embryos, TUNEL-positive cells were significantly increased in
the tailbud regions compared to control embryos (Figure 5A,B). In contrast, cell proliferation in the
tailbud region was significantly decreased in gpx3 morphant embryos (Figure 5C,D). Together, our data
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apoptotic  induction  through  caspase‐3  activation  [38,41].  In  this  study,  we  found  that  gpx3 
suppression results in increased ROS levels (Figure 3) and gene expression associated with apoptosis 
Figure 5. gpx3 suppression activates apoptosis and inhibits cell proliferation in gpx3 morphants.
(A) The expression and number of terminal deoxynucleotidyl transferase dUTP nick end labeling
(TUNEL)-positive cells were higher in gpx3 knockdown embryos compared to control embryos.
(B) Relative TUNEL expression, indicating a significant increase in apoptotic cells in gpx3 morphants.
** p < 0.001. (C) gpx3 loss resulted in reduced phospho-histone 3 (PH3)-positive cells in the tail region
of gpx3 knockdown embryos. PH3-positive cells are indicated by the color purple, whereas β-gal
staining is indicated by the color blue. (D) The relative PH3 expression showed cell proliferation was
significantly reduced by gpx3 knockdown. * p < 0.05.
4. Discussion
GPx3 belongs to an important class of selenoproteins [8] and is among the strongest antioxidant
enzymes by catalyzing peroxide reduction and free radicals through reduced glutathione to oxidized
glutathione [17]. GPx3 is well known for its roles in tumor suppression, and increased GPx3 expression
may als play a protective role in cardiomyocytes by ROS det xification [15,17,22,38]. Studies have
shown that reduced GPx3 expression is associate with liver and heart disease in humans [24,39].
However, GPx3’s role in embryonic development and ontogenesis has not yet been elucidated.
I this study, systematically assessed gpx3’s spatiot mporal expr ssion pattern during
embryonic development in Xenopus. RT-PCR analysis revealed that gpx3 is expressed at the late
blastula stage, with the highest expression at the early tailbud stage (Figure 1A). The spatial expression
pattern showed that gpx3 is localized at the tail region during Xenopus embryogenesis (Figure 1B).
gpx3’s involvement in tailbud develo ment was verified by gpx3 MO microinjection into the embryo
ventral blastomere at the 4-cell stage. gpx3 depletion led to a shortened post-anal tail compared
to control embryos (Figure 1C,D). To our surprise, gpx3 depletion did not affect early tailbud
gene expressio required for tailbud development (Figure 2C,D). Instead, gpx3 ablation perturbed
gene expression associated with signaling pathways involved in tailbud outgrowth during Xenopus
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embryonic development (Figure 2A,B). These data suggest that gpx3 is associated with signaling
pathways that are required for proper embryogenesis.
Cell death and renewal are indispensable processes in multicellular organisms and are required
for proper tissue and organ development [40]. Apoptosis occurs in multicellular organisms and is
required for removing abnormal cells and aids in internal environment stability and multiple system
development [41]. GPx3 induces apoptosis in cardiomyocytes, and excessive ROS levels can lead to
apoptotic induction through caspase-3 activation [38,41]. In this study, we found that gpx3 suppression
results in increased ROS levels (Figure 3) and gene expression associated with apoptosis signaling,
Fas signaling, and toll receptor signaling. These findings suggest that gpx3 regulates embryonic
development by controlling ROS levels and cell death processes (Figure 4). To further verify these
findings, we performed TUNEL and PH3 staining to detect the gpx3 effect on cell death and cell
proliferation. The cell death rate was significantly increased, and cell proliferation was decreased in
gpx3 knockdown embryos (Figure 5).
5. Conclusions
In conclusion, apoptosis and cell proliferation are fundamental physiological processes for
embryonic development. gpx3 knockdown perturbs proper tailbud development by activating cell
death and inhibiting cell proliferation. However, further work is needed to determine how gpx3
regulates Wnt, BMP, and Notch signaling pathways. Additionally, further investigation is required to
identify the regulatory mechanisms involved in gpx3-associated cell death during vertebrate embryonic
development, as our data confirmed that gpx3 knockdown is not associated with activation of Nrf2
regulatory network.
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